Community Development Venture Capital Alliance
01/07/2026 | Press release | Archived content
Industry News: Excell Partners invests in ZetaGen Therapeutics, Inc.
Excell Partners, based in Rochester, NY, made a Series A round investment in ZetaGen Therapeutics Inc.'s (ZetaGen), as a follow-on investment. ZetaGen, a Syracuse, NY-based clinical-stage biopharmaceutical company seeks to stop cancer from growing or spreading by targeting certain biological pathways in the body. This investment will support ZetaGen's continued R&D efforts and create job opportunities in a low-income community. For more information, visit Excell Partners and ZetaGen Therapeutics.
Community Development Venture Capital Alliance published this content on January 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 02, 2026 at 09:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]